Cargando…
P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429480/ http://dx.doi.org/10.1097/01.HS9.0000847088.09306.08 |
| _version_ | 1784779457277460480 |
|---|---|
| author | Stegelmann, F. Jahn, E. Koschmieder, S. Heidel, F. Hochhaus, A. Hebart, H. Isfort, S. Reiter, A. Bangerter, M. Waller, C. F. Wolleschak, D. Scheid, C. Göthert, J. Schafhausen, P. Kindler, T. Radsak, M. P. Gattermann, N. Möhle, R. von Bubnoff, N. Schrade, A. Brümmendorf, T. Döhner, H. Griesshammer, M. Döhner, K. |
| author_facet | Stegelmann, F. Jahn, E. Koschmieder, S. Heidel, F. Hochhaus, A. Hebart, H. Isfort, S. Reiter, A. Bangerter, M. Waller, C. F. Wolleschak, D. Scheid, C. Göthert, J. Schafhausen, P. Kindler, T. Radsak, M. P. Gattermann, N. Möhle, R. von Bubnoff, N. Schrade, A. Brümmendorf, T. Döhner, H. Griesshammer, M. Döhner, K. |
| author_sort | Stegelmann, F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94294802022-08-31 P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA Stegelmann, F. Jahn, E. Koschmieder, S. Heidel, F. Hochhaus, A. Hebart, H. Isfort, S. Reiter, A. Bangerter, M. Waller, C. F. Wolleschak, D. Scheid, C. Göthert, J. Schafhausen, P. Kindler, T. Radsak, M. P. Gattermann, N. Möhle, R. von Bubnoff, N. Schrade, A. Brümmendorf, T. Döhner, H. Griesshammer, M. Döhner, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429480/ http://dx.doi.org/10.1097/01.HS9.0000847088.09306.08 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Stegelmann, F. Jahn, E. Koschmieder, S. Heidel, F. Hochhaus, A. Hebart, H. Isfort, S. Reiter, A. Bangerter, M. Waller, C. F. Wolleschak, D. Scheid, C. Göthert, J. Schafhausen, P. Kindler, T. Radsak, M. P. Gattermann, N. Möhle, R. von Bubnoff, N. Schrade, A. Brümmendorf, T. Döhner, H. Griesshammer, M. Döhner, K. P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title | P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title_full | P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title_fullStr | P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title_full_unstemmed | P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title_short | P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA |
| title_sort | p1055: clinical and genetic results of the phase ib/ii trial mpnsg-0212: ruxolitinib plus pomalidomide in myelofibrosis with anemia |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429480/ http://dx.doi.org/10.1097/01.HS9.0000847088.09306.08 |
| work_keys_str_mv | AT stegelmannf p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT jahne p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT koschmieders p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT heidelf p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT hochhausa p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT hebarth p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT isforts p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT reitera p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT bangerterm p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT wallercf p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT wolleschakd p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT scheidc p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT gothertj p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT schafhausenp p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT kindlert p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT radsakmp p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT gattermannn p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT mohler p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT vonbubnoffn p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT schradea p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT brummendorft p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT dohnerh p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT griesshammerm p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia AT dohnerk p1055clinicalandgeneticresultsofthephaseibiitrialmpnsg0212ruxolitinibpluspomalidomideinmyelofibrosiswithanemia |